Bayer initiates Phase II study of sGC activator in chronic kidney disease
PremiumThe FlyBayer initiates Phase II study of sGC activator in chronic kidney disease
29d ago
Bayer commences ALPINE-1 study
Premium
The Fly
Bayer commences ALPINE-1 study
29d ago
Applied Materials, H&R Block report quarterly beats: Morning Buzz
Premium
The Fly
Applied Materials, H&R Block report quarterly beats: Morning Buzz
1M ago
0P6S Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings0P6S Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Bayer’s Monsanto to pay Seattle $160M to settle pollution claims
Premium
The Fly
Bayer’s Monsanto to pay Seattle $160M to settle pollution claims
2M ago
Oric announces clinical collaborations with Bayer, Janssen
Premium
The Fly
Oric announces clinical collaborations with Bayer, Janssen
2M ago
Bayer initiated with a Neutral at Goldman Sachs
PremiumThe FlyBayer initiated with a Neutral at Goldman Sachs
4M ago
Bayer: Secondary endpoints met in elinzanetant study for menopause symptoms
Premium
The Fly
Bayer: Secondary endpoints met in elinzanetant study for menopause symptoms
4M ago
Bayer sees FY24 core EPS EUR 5.10- EUR 5.50
Premium
The Fly
Bayer sees FY24 core EPS EUR 5.10- EUR 5.50
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100